Skip to main content

Gain a Truer Picture of Disease Prevalence

Optum Enlighten is a groundbreaking pharma intelligence platform that identifies disease prevalence in populations at a hyper-local level.

Advanced analytics and predictive modeling

  • Understand obstacles preventing members getting diagnosed*
  • View the current and future market share of medications specific to targeted sub-populations, regions and providers
  • Identify the true population eligible for a specific drug
  • Prioritize locations and providers with the highest access to potential consumers

Key benefits

Learn how our pharma intelligence platform can help you get the data you need.

Stratify with specifics

Stratify medical and prescription claims data of 30 million real-world lives — diagnoses, procedures, prescriptions and labs — to spot disease prevalence.

Identify patient cohorts

Using more than 70 predictive models and 200 rules, find patient cohorts suspected of having the disease you’re targeting.

Narrow further

Drill further to the provider level, enabling you to sharpen your sales strategy.

How does it work?

Find candidates for your drug by selecting the relevant condition, along with the stratification criteria. Drill down into high prevalence areas to find a provider-based target population.

Interested in seeing the state and hyper-local detail?

A closer look

See how our predictive models and clinical rules identify disease prevalence and relevant patient cohorts.

Severe Asthma

Heart Failure

Alzheimer’s Disease

Learn more about Optum Enlighten

Get all the details about this pharma intelligence platform to give you the advanced analytics and predictive data.

Get started. To learn more about Enlighten, contact us.

 

*While the model will predict a diagnosis, it still falls solely on the provider to make this diagnosis.